94 related articles for article (PubMed ID: 2788801)
21. Immunologic assessment of host defense impairment in patients with septic multiple organ failure: relationship between complement activation and changes in neutrophil function.
Goya T; Morisaki T; Torisu M
Surgery; 1994 Feb; 115(2):145-55. PubMed ID: 8310402
[TBL] [Abstract][Full Text] [Related]
22. Plasma interleukin 8 and polymorphonuclear leukocyte elastase concentrations in patients with septic shock.
Endo S; Inada K; Ceska M; Takakuwa T; Yamada Y; Nakae H; Kasai T; Yamashita H; Taki K; Yoshida M
J Inflamm; 1995; 45(2):136-42. PubMed ID: 7583359
[TBL] [Abstract][Full Text] [Related]
23. Enhanced release of elastase is not concomitant with increased secretion of granulocyte-activating cytokines in whole blood from patients with sepsis.
Ertel W; Jarrar D; Jochum M; Thiele V; Kenney J; Faist E; Schildberg FW
Arch Surg; 1994 Jan; 129(1):90-7; discussion 97-8. PubMed ID: 8279945
[TBL] [Abstract][Full Text] [Related]
24. A neutrophil elastase inhibitor, sivelestat, improves leukocyte deformability in patients with acute lung injury.
Inoue Y; Tanaka H; Ogura H; Ukai I; Fujita K; Hosotsubo H; Shimazu T; Sugimoto H
J Trauma; 2006 May; 60(5):936-43; discussion 943. PubMed ID: 16688053
[TBL] [Abstract][Full Text] [Related]
25. The effect of ulinastatin, a human protease inhibitor, on the transfusion-induced increase of plasma polymorphonuclear granulocyte elastase.
Nishiyama T; Aibiki M; Hanaoka K
Anesth Analg; 1996 Jan; 82(1):108-12. PubMed ID: 8712383
[TBL] [Abstract][Full Text] [Related]
26. [Can ulinastatin be an effective inhibitor of human polymorphonuclear granulocyte elastase under severe stressed state?].
Ishikawa A; Fukao K; Tsuji K; Osada A; Yamamoto Y; Iwasaki Y
Nihon Geka Gakkai Zasshi; 1993 May; 94(5):449-55. PubMed ID: 8332119
[TBL] [Abstract][Full Text] [Related]
27. Formation of polymorphonuclear leukocyte elastase: alpha 1 proteinase inhibitor complex and A alpha (1-21) fibrinopeptide in human blood stimulated with the calcium ionophore A23187. A model to characterize inhibitors of polymorphonuclear leukocyte elastase.
Pacholok SG; Davies P; Dorn C; Finke P; Hanlon WA; Mumford RA; Humes JL
Biochem Pharmacol; 1995 May; 49(10):1513-20. PubMed ID: 7763294
[TBL] [Abstract][Full Text] [Related]
28. Posttraumatic plasma levels of mediators of organ failure.
Jochum M; Dwenger A; Joka T; Sturm J
Prog Clin Biol Res; 1989; 308():673-81. PubMed ID: 2789397
[No Abstract] [Full Text] [Related]
29. Plasma polymorphonuclear elastase in patients with hyperthyroidism.
Hara H; Ban Y
Endocr J; 1993 Dec; 40(6):711-4. PubMed ID: 7951541
[TBL] [Abstract][Full Text] [Related]
30. Nitrite/nitrate (NOx) and sFas antigen levels in patients with multiple organ failure.
Endo S; Inada K; Takakuwa T; Kasai T; Yamada Y; Wakabayashi G; Niimi M; Suzuki T; Taniguchi S
Res Commun Mol Pathol Pharmacol; 1996 May; 92(2):253-6. PubMed ID: 8774078
[TBL] [Abstract][Full Text] [Related]
31. [Lung injury in idiopathic pulmonary fibrosis and measurement of immunoreactive neutrophil elastase and alpha 1-protease inhibitor in blood].
Kusume K
Nihon Kyobu Shikkan Gakkai Zasshi; 1991 Oct; 29(10):1254-60. PubMed ID: 1753502
[TBL] [Abstract][Full Text] [Related]
32. Role of granulocyte elastase in tissue injury in patients with septic shock complicated by multiple-organ failure.
Tanaka H; Sugimoto H; Yoshioka T; Sugimoto T
Ann Surg; 1991 Jan; 213(1):81-5. PubMed ID: 1985543
[TBL] [Abstract][Full Text] [Related]
33. Neutrophil-derived circulating free DNA (cf-DNA/NETs): a potential prognostic marker for posttraumatic development of inflammatory second hit and sepsis.
Margraf S; Lögters T; Reipen J; Altrichter J; Scholz M; Windolf J
Shock; 2008 Oct; 30(4):352-8. PubMed ID: 18317404
[TBL] [Abstract][Full Text] [Related]
34. [Evaluation of the elastase burden in patients with idiopathic interstitial pneumonia].
Kamei T; Fujita J; Yamaji Y; Takahara J
Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Sep; 31(9):1081-8. PubMed ID: 8255016
[TBL] [Abstract][Full Text] [Related]
35. Expression of monocyte human leukocyte antigen-DR in relation with sepsis severity and plasma mediators.
Payen D; Faivre V; Lukaszewicz AC; Villa F; Goldberg P
Minerva Anestesiol; 2009 Sep; 75(9):484-93. PubMed ID: 19644434
[TBL] [Abstract][Full Text] [Related]
36. Relationship between neopterin and granulocyte elastase plasma levels and the severity of multiple organ failure.
Pacher R; Redl H; Frass M; Petzl DH; Schuster E; Woloszczuk W
Crit Care Med; 1989 Mar; 17(3):221-6. PubMed ID: 2784090
[TBL] [Abstract][Full Text] [Related]
37. A multicenter study of phospholipase A2 in patients in intensive care units.
Uhl W; Beger HG; Hoffmann G; Hanisch E; Schild A; Waydhas C; Entholzner E; Müller K; Kellermann W; Vogeser M
J Am Coll Surg; 1995 Mar; 180(3):323-31. PubMed ID: 7874343
[TBL] [Abstract][Full Text] [Related]
38. Participation and interactions of neutrophil elastase in haemostatic disorders of patients with severe infections.
Seitz R; Wolf M; Egbring R; Radtke KP; Liesenfeld A; Pittner P; Havemann K
Eur J Haematol; 1987 Mar; 38(3):231-40. PubMed ID: 3297774
[TBL] [Abstract][Full Text] [Related]
39. Leucocyte elastase activity in meningococcal septicaemia associated coagulopathy.
Canavan D; Robinson F; Turkington P
J Clin Pathol; 1986 Dec; 39(12):1304-5. PubMed ID: 3492517
[TBL] [Abstract][Full Text] [Related]
40. Chemical, biochemical, pharmacokinetic, and biological properties of L-680,833: a potent, orally active monocyclic beta-lactam inhibitor of human polymorphonuclear leukocyte elastase.
Doherty JB; Shah SK; Finke PE; Dorn CP; Hagmann WK; Hale JJ; Kissinger AL; Thompson KR; Brause K; Chandler GO
Proc Natl Acad Sci U S A; 1993 Sep; 90(18):8727-31. PubMed ID: 8378355
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
